Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients
Crossref DOI link: https://doi.org/10.1007/s12032-014-0159-5
Published Online: 2014-08-14
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Li
Shi, Yan
Yuan, Jing
Wu, Qian
Han, Yalin
Qin, Rui
Jia, Baoqing
Wei, Bo
Wei, Lixin
Dai, Guanghai
Jiao, Shunchang
Text and Data Mining valid from 2014-08-14